🇺🇸 FDA
Patent

US 11590179

Bifidobacterium longum able to beneficially modulate immune response to respiratory virus infection

granted A61KA61K35/66A61K35/745

Quick answer

US patent 11590179 (Bifidobacterium longum able to beneficially modulate immune response to respiratory virus infection) held by PrecisionBiotics Group Limited expires Mon Feb 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
PrecisionBiotics Group Limited
Grant date
Tue Feb 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K35/66, A61K35/745